Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis (TB) in Elderly Residents of Nursing Homes?

Is Tuberculin Skin Testing Effective in Screening for Latent TB in Elderly Residents of Nursing Homes? Comparison With a New IFN-y Based Assay

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00756808

Enrollment

135

Registered

2008-09-22

Start date

2007-10-31

Completion date

2010-07-31

Last updated

2014-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Keywords

latent tuberculosis in elderly

Brief summary

In face of the increased rates of tuberculosis in residents of long term care facilities, annual screening for latent tuberculosis is recommended. Tuberculin skin testing using purified protein derivative (PPD) is used for this purpose. Sensitivity of the PPD testing is, however, dependent on a normal T cell function. It is now evident that the immune system undergoes age-associated alteration known as immune senescence. The depressed T-cell responses may clinically manifest as attenuated delayed-type hypersensitivity. This attenuated reaction may affect the sensitivity of the PPD in detection of latent TB in the elderly. This prospective study will examine the utility of interferon-gamma (IFN-γ) based assay, T-SPOT.TB, for detection of latent tuberculosis in nursing home patients who are 65 years of age or older.

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

65 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* 65 years of age and older * No ulcerating or blistering skin disorder * No previous history of adverse reaction to PPD testing * No blood transfusion within 6 weeks prior to enrollment * If the participant had a PPD placed and read by a public health department representative within the last 6 months, repeat PPD will not be done, but the person may participate in the study * Participant may have been Bacille de Calmette et Guerin (BCG)-vaccinated

Exclusion criteria

* Less than 65 years * Not a resident of a long term care facility * Diagnosis of Tuberculosis * blood transfusion within 6 weeks of enrollment * Prior diagnosis of immune deficiency

Design outcomes

Primary

Measure	Time frame
detection of latent TB	2 years

Countries

United States

Outcome results